2013
DOI: 10.2310/7290.2012.00013
|View full text |Cite
|
Sign up to set email alerts
|

Efficient 18F Labeling of Cysteine-Containing Peptides and Proteins Using Tetrazine–Trans-Cyclooctene Ligation

Abstract: 18F PET has a number of attributes that make it clinically attractive, including nearly 100% positron efficiency, very high specific radioactivity, and short half-life of ~110 min. However, the short half-life of 18F and the poor nucleophilicity of fluoride introduce challenges for the incorporation of 18F into complex molecules. Recently, the tetrazine-trans-cyclooctene ligation has been introduced as a novel 18F labeling method that proceeds with fast reaction rates without catalysis. Herein, we report an ef… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
39
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 50 publications
(39 citation statements)
references
References 30 publications
0
39
0
Order By: Relevance
“…27 As shown in Figure 1, 18 F-labeled TCO 2 could be obtained in high radiochemical yield (71%) by combining nosylate 1 with 18 F-fluoride (100 mCi). 18 F- 2 is an effective reagent for creating 18 F-labeled probes within seconds at low micromolar concentrations, and we have used this reagent to make cyclic RGD (cRGD) and VEGF protein conjugates for cancer imaging 28, 29 and exendin-4 conjugates for applications in insulinoma imaging and diabetes monitoring. 30 Notably, these conjugates were synthesized without using a large excess of the peptidic labeling precursor (Figure 1b).…”
Section: Introductionmentioning
confidence: 99%
“…27 As shown in Figure 1, 18 F-labeled TCO 2 could be obtained in high radiochemical yield (71%) by combining nosylate 1 with 18 F-fluoride (100 mCi). 18 F- 2 is an effective reagent for creating 18 F-labeled probes within seconds at low micromolar concentrations, and we have used this reagent to make cyclic RGD (cRGD) and VEGF protein conjugates for cancer imaging 28, 29 and exendin-4 conjugates for applications in insulinoma imaging and diabetes monitoring. 30 Notably, these conjugates were synthesized without using a large excess of the peptidic labeling precursor (Figure 1b).…”
Section: Introductionmentioning
confidence: 99%
“…Applications of these two reactions include labeling biomolecules in cells and cancer diagnostics. 2224 Here, we report kinetic investigations of IEDDAC and NADC reactions that involve strained alkene/alkyne functionalities including norbornene, trans -cyclooctene, and cyclooctyne, and their applications in labeling proteins that are genetically modified with these functional groups.…”
Section: Introductionmentioning
confidence: 99%
“…7 Protein-labeling using prosthetic 18 F-synthons has been developed and applied to a variety of substrates, generally targeting either lysine 8−11 or cysteine 1214 residues. Some variants employ heterobifunctional cross-linkers to Lys/Cys, allowing a two-step process combining other modification chemistries 15−21 or even complexation. 22,23 However, these protein-labeling techniques can result in nonspecific labeling, which may affect the biological activity and typically generate mixtures of differently labeled proteins as product.…”
mentioning
confidence: 99%